Literature DB >> 32048943

Prognostic Significance of Patient-Reported Outcomes in Cancer.

Kathleen Kerrigan1, Shiven B Patel1, Benjamin Haaland1, Dominik Ose1, Anna Weinberg Chalmers1, Tyler Haydell2, Neal J Meropol2, Wallace Akerley1.   

Abstract

PURPOSE: Performance status (PS), an established prognostic surrogate of cancer survival, is a physician-synthesized metric of patient symptoms and mobility that is prone to bias and subjectivity. The National Cancer Institute (NCI) Patient-Reported Outcomes Measurement Information System-Cancer (PROMIS-Ca) Bank, a patient-centric patient-reported outcome (PRO) evaluation of physical function (PF), fatigue, depression, anxiety, and pain, shares subject matter with PS and, therefore, may also be prognostic while eliminating physician interpretation.
METHODS: Patients at Huntsman Cancer Institute were assessed using the NCI PROMIS-Ca Bank. Using tablets at routine office visits, PF, fatigue, depression, anxiety, and pain scores were collected from patients with advanced melanoma, non-small-cell lung cancer, colorectal cancer, and breast cancer. A PRO score collected at a single time point within 6 months of metastatic diagnosis for each patient was merged with curated clinical outcome data. The association of PROs, overall survival (OS), and hospitalization-free survival (HFS) were assessed in multivariable analysis that included sex and cancer type.
RESULTS: Two hundred eighty-two complete sets of patient data were available for analysis. All 5 PRO domains were strongly prognostic of OS and HFS. While the PRO domains were interrelated with moderate to strong correlations (0.40-0.79), multivariable regression suggested that PF was most strongly associated with the clinical outcomes of OS (P < .001) and HFS (P < .001).
CONCLUSION: NCI PROMIS-Ca PROs may be prognostic of both cancer survival and likelihood of hospitalization. Future prospective studies are needed for all major prognostic factors to fully understand the independent prognostic value of PROs.

Entities:  

Year:  2020        PMID: 32048943      PMCID: PMC7846047          DOI: 10.1200/JOP.19.00329

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN: 2688-1527


  23 in total

1.  Why do our patients get chemotherapy until the end of life?

Authors:  S Braga
Journal:  Ann Oncol       Date:  2011-09-13       Impact factor: 32.976

2.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Authors:  David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays
Journal:  J Clin Epidemiol       Date:  2010-08-04       Impact factor: 6.437

3.  Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .

Authors:  C J Sweeney; J Zhu; A B Sandler; J Schiller; C P Belani; C Langer; J Krook; D Harrington; D H Johnson
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

4.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

5.  Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer.

Authors:  Bradley J Barney; Xin Shelley Wang; Charles Lu; Zhongxing Liao; Valen E Johnson; Charles S Cleeland; Tito R Mendoza
Journal:  Qual Life Res       Date:  2013-01-31       Impact factor: 4.147

6.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Authors:  Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

7.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

Review 8.  The prognostic significance of patient-reported outcomes in cancer clinical trials.

Authors:  Carolyn C Gotay; Crissy T Kawamoto; Andrew Bottomley; Fabio Efficace
Journal:  J Clin Oncol       Date:  2008-01-28       Impact factor: 44.544

9.  Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.

Authors:  Sandra D Griffith; Rebecca A Miksad; Geoff Calkins; Paul You; Nicole G Lipitz; Ariel B Bourla; Erin Williams; Daniel J George; Deborah Schrag; Sean Khozin; William B Capra; Michael D Taylor; Amy P Abernethy
Journal:  JCO Clin Cancer Inform       Date:  2019-08

10.  Hospitalization Rates and Predictors of Rehospitalization Among Individuals With Advanced Cancer in the Year After Diagnosis.

Authors:  Robin L Whitney; Janice F Bell; Daniel J Tancredi; Patrick S Romano; Richard J Bold; Jill G Joseph
Journal:  J Clin Oncol       Date:  2017-08-29       Impact factor: 50.717

View more
  11 in total

Review 1.  Patient reported outcomes in oncology: changing perspectives-a systematic review.

Authors:  Augusta Silveira; Teresa Sequeira; Joaquim Gonçalves; Pedro Lopes Ferreira
Journal:  Health Qual Life Outcomes       Date:  2022-05-21       Impact factor: 3.077

2.  Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib.

Authors:  Sarah Badaoui; Ganessan Kichenadasse; Andrew Rowland; Michael J Sorich; Ashley M Hopkins
Journal:  Oncologist       Date:  2021-05-11

3.  Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.

Authors:  Kea Turner; Naomi C Brownstein; Zachary Thompson; Issam El Naqa; Yi Luo; Heather S L Jim; Dana E Rollison; Rachel Howard; Desmond Zeng; Stephen A Rosenberg; Bradford Perez; Andreas Saltos; Laura B Oswald; Brian D Gonzalez; Jessica Y Islam; Amir Alishahi Tabriz; Wenbin Zhang; Thomas J Dilling
Journal:  Radiother Oncol       Date:  2021-12-23       Impact factor: 6.280

Review 4.  Beyond Performance Status.

Authors:  R Simcock; J Wright
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-07-16       Impact factor: 4.126

5.  An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice.

Authors:  Miss Charlotte L Moss; Ajay Aggarwal; Asad Qureshi; Benjamin Taylor; Teresa Guerrero-Urbano; Mieke Van Hemelrijck
Journal:  Health Qual Life Outcomes       Date:  2021-01-15       Impact factor: 3.186

6.  Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.

Authors:  Bastien Collomb; Amélie Dubromel; Anne Gaëlle Caffin; Chloé Herledan; Virginie Larbre; Amandine Baudouin; Ariane Cerutti; Laurence Couturier; Magali Maire; Lionel Karlin; Delphine Maucort-Boulch; Laure Huot; Stéphane Dalle; Emmanuel Bachy; Hervé Ghesquieres; Gilles Salles; Sébastien Couraud; Benoit You; Gilles Freyer; Véronique Trillet-Lenoir; Florence Ranchon; Catherine Rioufol
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

7.  The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy.

Authors:  Sarah Badaoui; Adel Shahnam; Michael J Sorich; Ashley M Hopkins; Ross A McKinnon; Ahmad Y Abuhelwa
Journal:  Transl Lung Cancer Res       Date:  2022-03

8.  Completion of Patient-Reported Outcome Questionnaires Among Older Adults with Advanced Cancer.

Authors:  Marie A Flannery; Supriya Mohile; Eva Culakova; Sally Norton; Charles Kamen; J Nicholas Dionne-Odom; Grace DiGiovanni; Lorraine Griggs; Thomas Bradley; Judith O Hopkins; Jane Jijun Liu; Kah Poh Loh
Journal:  J Pain Symptom Manage       Date:  2021-08-08       Impact factor: 3.612

9.  A systematic review of rehabilitation and exercise recommendations in oncology guidelines.

Authors:  Nicole L Stout; Daniel Santa Mina; Kathleen D Lyons; Karen Robb; Julie K Silver
Journal:  CA Cancer J Clin       Date:  2020-10-27       Impact factor: 508.702

10.  Age Is Not a Barrier: Older Adults With Cancer Derive Similar Benefit in a Randomized Controlled Trial of a Remote Symptom Monitoring Intervention Compared With Younger Adults.

Authors:  Lorinda A Coombs; Lee Ellington; Angela Fagerlin; Kathi Mooney
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.